Læknablaðið - 15.10.2001, Side 33
FRÆÐIGREINAR / HÓMÓCYSTEIN, FÓLAT, KÓBALAMÍN
10. Rasmussen K, Möller J, Lyngbak M, Holm Pedersen A-M,
Dybkjær L. Age- and gender-specific reference intervals for
total homocysteine and methylmalonic acid in plasma before
and after vitamin supplementation. Clin Chem 1996; 42: 4,
630-6.
11. Arnadottir M, Gudnason V, Hultberg B. Treatment with
different doses of folic acid in haemodialysis patients: effects
on folate distribution and aminothiol concentrations. Nephrol
Dial Transplant 2000; 15: 524-8.
12. Rasmussen K, Möller J. Total homocysteine measurement in
clinical practice. Ann Clin Biochem 2000; 37: 627-48.
13. Solberg HE. RefVal: a program implementing the recommen-
dations of the International Federation of Clinical Chemistry
on the statistical treatment of reference values. Comput
Methods Programs Biomed 1995; 48:247-56.
14. Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson
PWF, Belanger AJ, et al. Association between plasma homo-
cysteine and extra-cranial carotid-artery sclerosis. N Engl J
Med 1995; 332: 286-91.
15. Rossi E, Beilby JP, McQuillan BM, Hung J. Biological varia-
bility and reference intervals for total plasma homocysteine.
Ann Clin Biochem 1999; 36: 56-61.
16. Malinow MR. Plasma homocyst(e)ine and arterial occlusive
disease: a mini-review. Clin Chem 1995; 41:173-6.
17. denHeijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL,
Wijermans PW, et al. Is hyperhomocysteinaemia a risk factor
for recurrent venous thrombosis? Lancet 1995; 345: 882-5.
18. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine
and cardiovascular disease. Ann Rev Med 1998; 49: 31-62.
19. Wald N, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM.
Homocysteine and ischemic heart disease. Arch Intern Med
1998; 158: 862-7.
20. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH.
Vitamin status and intake as primary determinants of homo-
cysteinemia in an elderly population. JAMA 1993; 270:2693-8.
21. Garg UC, Zheng ZJ, Folsom AR, Moyer YS, Tsai MY, Mc-
Govern P, et al. Short-term and long-term variability of plasma
homocysteine measurements. Clin Chem 1997; 43:141-5.
22. Clarke R, Woodhouse P, Ulvik Afrost C, Sherliker P, Refsum
H, Ueland PM, et al. Variability and determinants of total
homocysteine concentrations in plasma in an elderly popula-
tion. Clin Chem 1998; 44:102-7.
23. Rasmussen K, Möller J, Lyngbak M. Within-person variation
of plasma homocysteine and effects of posture and tourniquet
application. Clin Chem 1999; 45:1850-5.
Heartstream
FR2
Hjartastopp getur hent hvern sem er,
hvenær sem er,
hvar sem er...
iék mh fkiys hftwf
Læknablaðið 2001/87 797